首頁 > 市場調查報告書 > 醫療設備

導管

腫瘤消融市場規模、佔有率和成長分析（按最終用戶、應用和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1900234

腫瘤消融市場規模、佔有率和成長分析（按最終用戶、應用和地區分類）—2026-2033年產業預測

Tumor Ablation Market Size, Share, and Growth Analysis, By End User (Hospitals & Clinics, Cancer Care CentersRadiofrequency Ablation), By Application (Kidney Cancer, Liver Cancer), By Region -Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，腫瘤消融市場規模將達到 21.7 億美元，到 2025 年將達到 24.8 億美元，到 2033 年將達到 71.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 14.2%。

全球癌症發生率的不斷攀升，以及微創治療方法的日益增多，正推動腫瘤消融手術的需求成長。消融技術的創新為醫療服務提供者開闢了新的可能性，而門診治療的日益普及和聯合治療的廣泛應用，預計將進一步促進腫瘤消融產品市場的擴張。對先進癌症治療的需求不斷成長，以及腫瘤學研究投入的增加，也為該領域創造了更多商機。中低收入國家癌症病例的快速成長蘊藏著巨大的市場潛力。然而，設備成本高昂、傳統治療方法的競爭以及發展中地區認知度不足等挑戰，可能會阻礙市場的長期成長。

腫瘤消融市場促進因素

全球癌症發生率的不斷攀升是腫瘤消融手術需求日益成長的主要原因。這種微創治療方法正逐漸成為治療肝癌、肺癌和腎臟癌的首選方法，尤其適用於不適合傳統手術的患者。隨著癌症發生率的持續上升，對腫瘤消融等高效能微創治療方法的需求變得更加迫切，市場潛力也隨之成長。腫瘤消融能夠提供標靶治療並縮短恢復期，使其成為醫護人員和患者都極具吸引力的選擇。

限制腫瘤消融市場發展的因素

由於技術先進的腫瘤消融設備高成本，腫瘤消融市場面臨嚴峻的挑戰。這些高昂的價格增加了治療的總成本，使得預算緊張的醫療機構難以購買和運作這些關鍵設備。因此，腫瘤消融設備的經濟負擔構成了一大障礙，限制了市場成長和在各類醫療機構中的普及。這種經濟限制從根本上影響了醫療服務提供者提供創新治療方案的能力，並最終阻礙了腫瘤消融市場的發展。

腫瘤消融市場趨勢

在腫瘤消融市場，先進影像導引技術的整合正日益成為主流趨勢。這些技術能夠提高手術精準度，改善患者預後。即時成像技術，例如磁振造影（MRI）、電腦斷層掃描（CT）和超音波，正變得至關重要。這些技術使臨床醫生能夠精確定位腫瘤，從而最大限度地減少併發症，提高消融手術的成功率。隨著微創治療需求的不斷成長，預計該領域的公司將優先發展成像技術，這將最終改變患者照護，並鞏固其在不斷發展的癌症治療領域的競爭優勢。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic plc（Ireland）
Boston Scientific Corporation（USA）
Johnson & Johnson（USA）
Abbott Laboratories（USA）
Varian Medical Systems, Inc.（USA）
Olympus Corporation（Japan）
AngioDynamics, Inc.（USA）
Terumo Corporation（Japan）
Siemens Healthineers AG（Germany）
Merit Medical Systems, Inc.（USA）
EDAP TMS SA（France）
Stryker Corporation（USA）
Hologic, Inc.（USA）
IceCure Medical Ltd.（Israel）
Galil Medical, Inc.（USA）
ConMed Corporation（USA）
Neuwave Medical, Inc.（USA）
SonaCare Medical LLC.（USA）
Mermaid Medical A/S（Denmark）

結論與建議

簡介目錄

Product Code: SQMIG35A2494

Tumor Ablation Market size was valued at USD 2.17 Billion in 2024 and is poised to grow from USD 2.48 Billion in 2025 to USD 7.17 Billion by 2033, growing at a CAGR of 14.2% during the forecast period (2026-2033).

The increasing global prevalence of cancer, combined with a growing preference for minimally invasive treatment options, is driving demand for tumor ablation procedures. Innovations in ablation technologies are set to unlock new avenues for providers, while the rising trend of utilizing outpatient facilities and the popularity of combination therapies will likely enhance the market for tumor ablation products. The escalating demand for advanced cancer treatments and heightened investments in oncology research are creating further business opportunities within this sector. Low to middle-income countries present significant potential due to a rapid uptick in cancer cases. However, challenges such as high equipment costs, competition from traditional treatments, and limited awareness in developing regions may hinder long-term market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tumor Ablation Market Segments Analysis

Global Tumor Ablation Market is segmented by Technology, Treatment, Application, End User and region. Based on Technology, the market is segmented into Radiofrequency, Microwave, Irreversible Electroporation and Cryoablation. Based on Treatment, the market is segmented into Surgical Ablation, Percutaneous Ablation and Laparoscopic Ablation. Based on Application, the market is segmented into Lung Cancer, Kidney Cancer and Liver Cancer. Based on End User, the market is segmented into Hospitals and Clinics and Specialty Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Tumor Ablation Market

The rising global prevalence of cancer significantly contributes to the growing demand for tumor ablation procedures. This minimally invasive treatment is increasingly favored for managing liver, lung, and kidney cancers, particularly among patients who are not candidates for traditional surgical options. As the incidence of cancer continues to escalate, the need for effective and less invasive treatment alternatives like tumor ablation becomes even more critical, thereby boosting its market potential. The ability to provide targeted therapy with reduced recovery time makes tumor ablation an attractive option for both medical professionals and patients alike.

Restraints in the Tumor Ablation Market

The tumor ablation market faces significant challenges due to the high costs associated with tumor ablation equipment, which typically employs advanced technologies. These elevated prices contribute to the overall expense of treatment, making it difficult for healthcare facilities with constrained budgets to access and implement these essential tools. As a result, the financial burden of tumor ablation devices serves as a considerable barrier, limiting market growth and accessibility for various healthcare settings. This economic constraint fundamentally impacts the ability of providers to offer innovative treatment options, ultimately hindering advancements in the tumor ablation market.

Market Trends of the Tumor Ablation Market

The tumor ablation market is increasingly trending towards the integration of advanced imaging guidance technologies, which enhance procedural accuracy and improve patient outcomes. The utilization of real-time imaging modalities such as MRI, CT, and ultrasound is becoming essential, as these technologies enable clinicians to visualize tumor locations with precision, thereby minimizing complications and elevating success rates in ablation procedures. As the demand for minimally invasive treatments rises, companies in the sector are expected to prioritize research and development in imaging technologies, ultimately transforming patient care and solidifying their competitive edge in the evolving landscape of cancer treatment.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Tumor Ablation Market Size by Technology & CAGR (2026-2033)

Market Overview
Radiofrequency
Microwave
Irreversible Electroporation
Cryoablation

Global Tumor Ablation Market Size by Treatment & CAGR (2026-2033)

Market Overview
Surgical Ablation
Percutaneous Ablation
Laparoscopic Ablation

Global Tumor Ablation Market Size by Application & CAGR (2026-2033)

Market Overview
Lung Cancer
Kidney Cancer
Liver Cancer

Global Tumor Ablation Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Specialty Centers

Global Tumor Ablation Market Size & CAGR (2026-2033)

North America (Technology, Treatment, Application, End User)
- US
- Canada
Europe (Technology, Treatment, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Treatment, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Treatment, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Treatment, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Varian Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EDAP TMS S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IceCure Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galil Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ConMed Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuwave Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonaCare Medical LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mermaid Medical A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments